This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Cobiores Nv, Laregion Wallone, Life Sciences Research Partners Vzw. Active years: 2006-2020.
Location History:
- Herent, BE (2006 - 2008)
- Leuven, BE (2018 - 2020)
Company Filing History:
1 out of 1 
1 out of 4 
1 out of 41 
Years Active: 2006-2020
Title: André Trouet: Pioneering Cancer Chemotherapy Innovations
Introduction
André Trouet is a distinguished inventor based in Herent, Belgium, known for his significant contributions to cancer treatment through innovative prodrug therapies. He holds two patents that showcase his expertise in developing compounds aimed at improving the effectiveness of chemotherapy.
Latest Patents
Trouet's latest innovations include two notable patents:
1. **Prodrugs Activated by Plasmin and Their Use in Cancer Chemotherapy** - This invention introduces a modified therapeutic agent that consists of an oligopeptide with a plasmin peptide substrate. It features a therapeutic agent, stabilizing groups, and optional linker groups, allowing it to be cleaved by plasmin. The patent details methods of creating and using these prodrug compounds to enhance cancer treatment outcomes.
2. **Tumor-Activated Prodrug Compounds and Treatment** - In this patent, Trouet describes a compound (W-Z-M) that links therapeutic agents to ligands in a way that prevents their intracellular entry until they are cleaved by target cell factors. This selective activation ensures the therapeutic agents reach the intended cells, enhancing both efficacy and safety during treatment.
Career Highlights
Throughout his career, André Trouet has worked with reputable organizations, including Medarex Inc. and Laregion Wallone. His work has focused on innovative solutions for complex medical challenges, particularly in the field of oncology, where his research aims to improve the precision and effectiveness of cancer therapies.
Collaborations
In his professional journey, Trouet has collaborated with several notable figures in the scientific community, including Vincent Dubois and Alexandre Passioukov. These collaborations have fostered an environment of shared knowledge and innovation, contributing to the development of groundbreaking therapeutic approaches.
Conclusion
André Trouet's work as an inventor has cemented his position in the field of cancer chemotherapy. Through his patents, he continues to inspire advancements that aim to enhance treatment outcomes for patients suffering from cancer. His dedication to research and innovation exemplifies the importance of targeted therapies in modern medicine.